Special Investigation For Gist Of Sutent (Regulatory Post Marketing Commitment Plan).
All the patients whom an investigator prescribes the first SUNITINIB MALATE(Sutent) should
be registered.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Adverse drug reaction not expected from the LPD (unknown adverse drug reaction).
24 weeks
No
Pfizer CT.gov Call Center
Study Director
Pfizer
Japan: Institutional Review Board
A6181175
NCT00716820
May 2008
April 2014
Name | Location |
---|